Javascript must be enabled to continue!
Preparation of inactivated whole culture vaccine composed of Pasteurella multocida, Avibacterium paragallinarum , and Ornithobacterium rhinotracheale and evaluation of its protective
View through CrossRef
Abstract
Poultry, mainly chickens and its white meat represents one of the main, nutritionally valuable, and affordable red meat replacer source of protein throughout the whole world with special reference to developing countries. A long list of microbial agents especially bacterial pathogens threat chickens production cycles. They constitute one of the major problems facing the rapidly expanding poultry industry and are responsible for considerable economic losses.). Fowl Cholera, Infectious Coryza, and Ornithobacterium Rhinotracheale (ORT) diseases were among the serious bacterial infections that affect respiratory tract of chickens with an global adverse effect on poultry production. A formalized whole culture vaccine of composed of
P. multocida
serotypes A5, A8, A9 and D2,
Avibacterium paragallinarum
serotype A and C and
Ornithobacterium rhinotracheale
serotype A was prepared. This polyvalent vaccine proved to be safe producing no adverse side effects when injected in chickens. The immunizing efficacy of this vaccine was evaluated in SPF chickens, which were immunized at 6 weeks of age. The protective efficacy of the vaccine was determined using challenge test. The developed vaccine was effective in protecting chickens against Fowl Cholera, Infectious Coryza and Ornithobacterium Infection (ORT diseases) in chickens against challenge with these pathogens. Vaccinated chickens challenged with virulent
Pasteurella Multocida
serotypes A5, A8, A9 and D2 showed protection rates of 86.6%, 93.3%, 93.3% and 93.3%, respectively, as compared with 100% mortality in the non-vaccinated control. Vaccinated chickens challenged with
Avibacterium paragallinarum
serotypes A and C showed protection rates of 86.6% and 93.3%, respectively. Also, the protection rate against challenge with virulent
Ornithobacterium rhinotracheale
serotype A reached to 96.6%.
Title: Preparation of inactivated whole culture vaccine composed of
Pasteurella multocida, Avibacterium paragallinarum
, and
Ornithobacterium rhinotracheale
and evaluation of its protective
Description:
Abstract
Poultry, mainly chickens and its white meat represents one of the main, nutritionally valuable, and affordable red meat replacer source of protein throughout the whole world with special reference to developing countries.
A long list of microbial agents especially bacterial pathogens threat chickens production cycles.
They constitute one of the major problems facing the rapidly expanding poultry industry and are responsible for considerable economic losses.
).
Fowl Cholera, Infectious Coryza, and Ornithobacterium Rhinotracheale (ORT) diseases were among the serious bacterial infections that affect respiratory tract of chickens with an global adverse effect on poultry production.
A formalized whole culture vaccine of composed of
P.
multocida
serotypes A5, A8, A9 and D2,
Avibacterium paragallinarum
serotype A and C and
Ornithobacterium rhinotracheale
serotype A was prepared.
This polyvalent vaccine proved to be safe producing no adverse side effects when injected in chickens.
The immunizing efficacy of this vaccine was evaluated in SPF chickens, which were immunized at 6 weeks of age.
The protective efficacy of the vaccine was determined using challenge test.
The developed vaccine was effective in protecting chickens against Fowl Cholera, Infectious Coryza and Ornithobacterium Infection (ORT diseases) in chickens against challenge with these pathogens.
Vaccinated chickens challenged with virulent
Pasteurella Multocida
serotypes A5, A8, A9 and D2 showed protection rates of 86.
6%, 93.
3%, 93.
3% and 93.
3%, respectively, as compared with 100% mortality in the non-vaccinated control.
Vaccinated chickens challenged with
Avibacterium paragallinarum
serotypes A and C showed protection rates of 86.
6% and 93.
3%, respectively.
Also, the protection rate against challenge with virulent
Ornithobacterium rhinotracheale
serotype A reached to 96.
6%.
Related Results
Identification of serotypes of Mannheimia haemolytica and Pasteurella multocida from pneumonic cases of sheep and goats and their antimicrobial sensitivity profiles in Borana and Arsi zones, Ethiopia
Identification of serotypes of Mannheimia haemolytica and Pasteurella multocida from pneumonic cases of sheep and goats and their antimicrobial sensitivity profiles in Borana and Arsi zones, Ethiopia
AbstractRespiratory diseases caused by Mannheimia haemolytica (M. haemolytica) and Pasteurella multocida (P. multocida) have been known to result in a considerable loss due to mort...
Isolation and Identification of Pasteurella multocida and Mannheim Hemolytica from Pneumonic Small Ruminants in Haramaya District, Eastern Ethiopia
Isolation and Identification of Pasteurella multocida and Mannheim Hemolytica from Pneumonic Small Ruminants in Haramaya District, Eastern Ethiopia
Abstract
Background
Pasteurella species are frequently encountered as serious pathogens in small ruminants.
Methods
The cross-sectional study was conducted from December ...
Identification of Serotypes of Mannheimia haemolytica and Pasteurella multocida from pneumonic cases of sheep and goats and their antimicrobial sensitivity profiles in Borana and Arsi zones, Ethiopia
Identification of Serotypes of Mannheimia haemolytica and Pasteurella multocida from pneumonic cases of sheep and goats and their antimicrobial sensitivity profiles in Borana and Arsi zones, Ethiopia
Abstract
Respiratory diseases caused by M. haemolytica and P. multocida have been known to result in a considerable loss due to mortality and reduced production. This study...
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
Abstract
Purpose
In areas of Africa where ivermectin is widely used as prophylaxis against neglected tropical diseases, COVID-19 morbidity and mortality are markedly lower...
SPECIFIC ASPECTS OF AVIBACTERIUM PARAGALLINARUM INACTIVATION WITH FORMALDEHYDE AND THIOMERSAL
SPECIFIC ASPECTS OF AVIBACTERIUM PARAGALLINARUM INACTIVATION WITH FORMALDEHYDE AND THIOMERSAL
The paper demonstrates results of testing different modes of Avibacterium paragallinarum inactivation with formaldehyde and thiomersal. The bacterium destruction by 0.20% and 0.10%...
Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of a constructed aroA mutant
Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of a constructed aroA mutant
SummaryThe aroA gene from Pasteurella multocida was cloned by complementation of the Escherichia coli aroA mutant AB2829 with a DNA library constructed in pUC18. The nucleotide seq...
Molecular characteristic of Pasteurella multocida isolates from Sumba Island at East Nusa Tenggara Province, Indonesia
Molecular characteristic of Pasteurella multocida isolates from Sumba Island at East Nusa Tenggara Province, Indonesia
Aim: This study aimed to determine the molecular characteristics of Pasteurella multocida isolates originated from Sumba Island, East Nusa Tenggara Province.
Materials and Methods...
Identification of serotypes Pasteurella multocida and Mannheimia haemolytica from cattle and sheep in central Ethiopia
Identification of serotypes Pasteurella multocida and Mannheimia haemolytica from cattle and sheep in central Ethiopia
Abstract
Background: Pneumonic pasteurellosis is a multi-factorial respiratory disease of cattle and sheep caused by combination of etiologic agents; hence, reliable inform...

